Skip to main content
Top
Published in: Journal of Artificial Organs 2/2012

01-06-2012 | Case Report

Left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery in an adult

Authors: Koichi Kashiwa, Takashi Nishimura, Aya Saito, Hitoshi Kubo, Aoi Fukaya, Hisayoshi Tamai, Tomoyuki Yambe, Shunei Kyo, Minoru Ono

Published in: Journal of Artificial Organs | Issue 2/2012

Login to get access

Abstract

Since left heart bypass or biventricular circulatory assist with an extracorporeal centrifugal pump as a bridge to decision or recovery sometimes requires long-time support, the long-term durability of extracorporeal centrifugal pumps is crucial. The Rotaflow Centrifugal Pump® (MAQUET Cardiopulmonary AG, Hirrlingen, Germany) is one of the centrifugal pumps available for long-term use in Japan. However, there have been few reports of left heart bypass or biventricular circulatory support over the mid-term. This is a case report of left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery for an adult patient who could not be weaned from cardiopulmonary bypass and percutaneous cardiopulmonary support after cardiac surgery. We could confirm that the patient’s consciousness level was normal; however, the patient could not be weaned from the left heart bypass support lasting 1 month. Therefore, the circulatory assist device was switched to the extracorporeal Nipro ventricular assist device (VAD). This time, left heart bypass support could be maintained for 30 days using a single Rotaflow Centrifugal Pump®. There were no signs of hemolysis during left heart bypass support. The Rotaflow Centrifugal Pump® itself may be used as a device for a bridge to decision or recovery before using a VAD in cardiogenic shock patients.
Literature
1.
go back to reference John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.PubMed John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.PubMed
2.
go back to reference Gerrah R, Charette K, Chen JM. The first successful use of the Levitronix PediMag ventricular support device as a biventricular bridge to transplant in an infant. J Thorac Cardiovasc Surg. 2011;142:1282–3.PubMedCrossRef Gerrah R, Charette K, Chen JM. The first successful use of the Levitronix PediMag ventricular support device as a biventricular bridge to transplant in an infant. J Thorac Cardiovasc Surg. 2011;142:1282–3.PubMedCrossRef
3.
go back to reference Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–1.PubMedCrossRef Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–1.PubMedCrossRef
4.
go back to reference Mendler N, Podechtl F, Feil G, Hiltmann P, Sebening F. Seal-less centrifugal blood pump with magnetically suspended rotor: rot-a-flot. Artif Organs. 1995;19:620–4.PubMedCrossRef Mendler N, Podechtl F, Feil G, Hiltmann P, Sebening F. Seal-less centrifugal blood pump with magnetically suspended rotor: rot-a-flot. Artif Organs. 1995;19:620–4.PubMedCrossRef
5.
go back to reference Sato M, Kashiwabara S, Tanaka H, Tatsumi E, Takeno H. In vitro antithrombogenic evaluation of newly developed heparinized material. J Artif Organs. 1999;28:502–8. Sato M, Kashiwabara S, Tanaka H, Tatsumi E, Takeno H. In vitro antithrombogenic evaluation of newly developed heparinized material. J Artif Organs. 1999;28:502–8.
6.
go back to reference Nishinaka T, Tatsumi T, Katagiri N, Ohnishi H, Mizuno T, Shioya K, Tsukiya T, Homma A, Kashiwabara S, Tanaka H, Sato M, Taenaka Y. Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs. 2007;10:240–4.PubMedCrossRef Nishinaka T, Tatsumi T, Katagiri N, Ohnishi H, Mizuno T, Shioya K, Tsukiya T, Homma A, Kashiwabara S, Tanaka H, Sato M, Taenaka Y. Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs. 2007;10:240–4.PubMedCrossRef
7.
go back to reference Inoue T, Nishimura T, Murakami A, Itatani K, Takaoka T, Kitahori K, Umeki A, Takezoe T, Kashiwa K, Kyo S, Ono M. Left ventricular assist device support with a centrifugal pump for 2 months in a 5-kg child. J Artif Organs. 2011;14:253–6.PubMedCrossRef Inoue T, Nishimura T, Murakami A, Itatani K, Takaoka T, Kitahori K, Umeki A, Takezoe T, Kashiwa K, Kyo S, Ono M. Left ventricular assist device support with a centrifugal pump for 2 months in a 5-kg child. J Artif Organs. 2011;14:253–6.PubMedCrossRef
Metadata
Title
Left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery in an adult
Authors
Koichi Kashiwa
Takashi Nishimura
Aya Saito
Hitoshi Kubo
Aoi Fukaya
Hisayoshi Tamai
Tomoyuki Yambe
Shunei Kyo
Minoru Ono
Publication date
01-06-2012
Publisher
Springer Japan
Published in
Journal of Artificial Organs / Issue 2/2012
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-012-0632-x

Other articles of this Issue 2/2012

Journal of Artificial Organs 2/2012 Go to the issue